Elevated Blood Sugar, Lower Gray Matter Volume Linked To Depression

Health & Lifestyle
412

Listen to article (english)

Translate to Spanish or other 102 languages!

Blood sugar may be a potential risk factor for depression and influence gray matter volume in the brain. Image for illustration purposes
Blood sugar may be a potential risk factor for depression and influence gray matter volume in the brain. Image for illustration purposes

Medical News Today

- Advertisement -
  • An estimated 5% of all adults around the world live with depression. 
  • Fluctuations in a person’s blood sugar levels are a known risk factor for depression. 
  • Researchers from Sun Yat-sen University believe reduced gray matter volume in the brain may mediate the link between blood sugar levels and depression risk. 

About 5% of the entire world’s adult populationTrusted Source lives with depression — a mental disorder leaving a person feeling very sad and hopeless to the point where they do not enjoy their normal activities. 

There are quite a few risk factorsTrusted Source for depression, one of which is fluctuations in glycemia or a person’s blood sugar levels.

Follow the link below to read the full story on Medical News Today:

- Advertisement -

https://www.medicalnewstoday.com/articles/elevated-blood-sugar-lower-gray-matter-volume-linked-to-depression

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Summer Break Weight Gain Is Real, With Latino Children Especially at Risk
Next article
FDA Approves First Nonprescription Daily Oral Contraceptive

More Articles

Despite a Cure, Millions Remain Untreated for Hepatitis C

Mega Doctor News by University of Virginia Newswise — CHARLOTTESVILLE, Va. – Millions of Americans...

Updated Guidance Seeks to Reduce Risks From Pulmonary Embolism

Mega Doctor News American Heart Association Clark was 32 in the fall of...

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.
- Advertisement -